CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Net income (loss)	$ 10,515	$ (5,331)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization of property and equipment	3,164	3,146
Provision for doubtful accounts	25,851	27,176
Amortization of debt issuance costs	487	230
(Gain) loss on warrants	(39)	181
Noncash share-based compensation expense		40
Changes in operating assets and liabilities:
Accounts receivable	(23,523)	(19,174)
Inventories of supplies	(572)	(183)
Due from governmental payers	(302)	2,486
Prepaid expenses - hospital quality assurance fees		(44,727)
Prepaid income taxes		(4,269)
Hospital quality assurance fees receivable	(11,681)
Electronic health records incentive program receivable	(4,191)
Prepaid insurance, other prepaid expenses and current assets, and other assets	348	(1,924)
Accounts payable	453	3,968
Accrued compensation and benefits	301	(2,832)
Unearned revenue - hospital quality assurance fees		42,578
Income taxes payable	(10,776)
Accrued insurance retentions and other current liabilities	(3,822)	481
Net cash provided by (used in) operating activities	(13,787)	1,846
Cash flows from investing activities:
Decrease in restricted cash	13	2
Additions to property and equipment	(1,678)	(1,230)
Net cash used in investing activities	(1,665)	(1,228)
Cash flows from financing activities:
Proceeds from revolving line of credit, net	919	32,373
Debt issuance costs		(919)
Repayment of debt		(34,968)
Payment received - receivable from stockholders	132
Noncontrolling interests distributions	(1,414)	(2,000)
Payments on capital lease obligations	(724)	(668)
Net cash used in financing activities	(1,087)	(6,182)
Net decrease in cash and cash equivalents	(16,539)	(5,564)
Cash and cash equivalents, beginning of period	20,539	10,159
Cash and cash equivalents, end of period	4,000	4,595
Supplemental information:
Cash paid for interest	6,641	6,155
Cash paid for income taxes	$ 13,095